Health Condition 1: null- Mild to moderate anemia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Adolescent girls aged between 12-15years. 2) Adolescent girls with iron deficiency anemia (Hb 8 gm-12 gm%). 3) Adolescent whose parents were willing to give consent for clinical trial.
Exclusion criteria
Exclusion criteria: 1) Adolescent girls suffering from major systemic illness necessitating long term treatment. 2) Adolescent girls with evidence of malignancy. 3) Adolescent girls with concurrent serious hepatic dysfunction (defined as AST and/or ALT >3 times of the upper normal limit) or renal dysfunction (defined as S. creatinine >1.2mg/dl) uncontrolled pulmonary dysfunction (asthmatic and COPD patients) 4) Co-morbidity like TB, UTI and bleeding disorders etc. 5) H/o hypersensitivity to any of the trial drug or their ingredients. 6) Adolescent girls who have completed participation in any other clinical trial during the past six months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 9.9% Improvement in hemoglobin level and other symptoms of iron deficiency anemia .Timepoint: at the 28th day, 56th day and after follow up period of 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 38.09% relief observed with extremely significant P value in loss of appetiteTimepoint: at the 28th day, 56th day and after follow up period of 4 weeks | — |
Countries
India
Contacts
National Institute of Ayurveda